|      | col2                                                                                                     | col3 |
| ---- | -------------------------------------------------------------------------------------------------------- | ---- |
| Name | [Multi-Class Prediction of Cirrhosis Outcomes](https://www.kaggle.com/competitions/playground-series-s3e26) |      |
| Tags | Time Series Analysis Multi-Class                                                                         |      |
| Time | 2023-3                                                                                                   |      |

# Multi-Class Prediction of Cirrhosis Outcomes

æ•°æ®é›†æè¿°ï¼š
![1709354325504](image/Multi-ClassPredictionofCirrhosisOutcomes/1709354325504.png)

## **1.æŠ•ç¥¨æœ€é«˜çš„ç¬”è®°æœ¬**

### 1.1 [S3E26 | XGBClassifer](https://www.kaggle.com/code/markuslill/s3e26-xgbclassifer)

* é€’å½’ç‰¹å¾æ¶ˆé™¤ï¼ˆRFEï¼‰ç®—æ³•å¯èƒ½å¾ˆæœ‰è¶£ï¼Œä¾‹å¦‚ä½¿ç”¨Â sklearn.feature_selection.RFE [sklearnå­¦ä¹ â€”â€”é€’å½’ç‰¹å¾æ¶ˆé™¤æ³•ï¼ˆRFEï¼‰-CSDNåšå®¢](https://blog.csdn.net/weixin_42506939/article/details/116669848)
* è¯­æ³•ç³–

  ```python
  %%time 
  if GENERATE_REPORTS:
      # Generate the profile report
      profile = ProfileReport(df_train, title="YData Profiling Report - Cirrhosis")
      profile.to_notebook_iframe()
  ```
* é¥¼å›¾ï¼šç›®æ ‡å˜é‡æ˜¯ä¸å¹³è¡¡çš„ã€‚æ­¤å¤–ï¼Œå¤§å¤šæ•°æ‚£è€…éƒ½å—åˆ°å®¡æŸ¥ï¼ˆæ„å‘³ç€æ‚£è€…å¤±å»éšè®¿æˆ–ç ”ç©¶åœ¨æ‚£è€…æ­»äº¡æˆ–æ¥å—è‚ç§»æ¤ä¹‹å‰ç»“æŸï¼‰ã€‚è¿™æ˜¯ç”Ÿå­˜åˆ†æä¸­çš„å¸¸è§é—®é¢˜ã€‚
* æˆå¯¹å…³ç³»å›¾ï¼šä¸€äº›ç‰¹å¾å¯ä»¥é€šè¿‡çº¿æ€§æ–¹æ³•éå¸¸æœ‰æ•ˆåœ°åˆ†ç¦»ï¼ˆä»…æ£€æŸ¥äºŒç»´ç©ºé—´ï¼‰ã€‚å› æ­¤ï¼Œç»å…¸çš„ SVM æ–¹æ³•å¯èƒ½è¡¨ç°è¿˜ä¸é”™...... æ­¤å¤–ï¼Œç‰¹å¾åˆ†å¸ƒï¼ˆç›´æ–¹å›¾ï¼‰æ˜¾ç¤ºäº†ä¸€äº›æ¼‚äº®çš„â€œé’Ÿå½¢â€æ›²çº¿...... [Pythonå¯è§†åŒ– | Seaborn5åˆ†é’Ÿå…¥é—¨(ä¸ƒ)â€”â€”pairplot - çŸ¥ä¹ (zhihu.com)](https://zhuanlan.zhihu.com/p/98729226)
* å„ç§ç¼–ç åˆ—è¡¨ï¼š

| Encoding Technique         | Type of Variable | Support High Cardinality | Handle Unseen Variables | Cons                                         |
| -------------------------- | ---------------- | ------------------------ | ----------------------- | -------------------------------------------- |
| Label Encoding             | Nominal          | Yes                      | No                      | Unseen Variables                             |
| Ordinal Encoding           | Ordinal          | Yes                      | Yes                     | Categories interpreted as numerical values   |
| One-Hot / Dummy Encoding   | Nominal          | No                       | Yes                     | Dummy Variable Trap                          |
| Target Encoding            | Nominal          | Yes                      | Yes                     | Target LeakageÂ Uneven Category Distribution |
| Frequency / Count Encoding | Nominal          | Yes                      | Yes                     | Similar encodings                            |
| Binary Encoding            | Nominal          | Yes                      | Yes                     | Irreversible                                 |
| Hash Encoding              | Nominal          | Yes                      | Yes                     | Information Loss or Collision                |

* é™„åŠ åŠŸèƒ½ï¼š

  1. æ—¶é—´è®¡ç®—ï¼šé€šè¿‡æ—¥æœŸæˆ–æ—¶é—´æˆ³çš„å¤„ç†ï¼Œå¯ä»¥è®¡ç®—å‡ºä¸è¯Šæ–­æ—¥æœŸç›¸å…³çš„æ—¶é—´æµ‹é‡ï¼Œè¿™åœ¨åŒ»ç–—æ•°æ®åˆ†æä¸­å¾ˆå¸¸è§ã€‚
  2. åˆ†ç®±è½¬æ¢ï¼šå°†è¿ç»­å˜é‡ï¼ˆæ¯”å¦‚å¹´é¾„ï¼‰è½¬æ¢ä¸ºåˆ†ç±»å˜é‡ï¼Œæœ‰åŠ©äºç®€åŒ–æ¨¡å‹çš„å¤æ‚æ€§ï¼Œå¹¶ä¸”å¯ä»¥æ›´å¥½åœ°æ•æ‰å˜é‡ä¹‹é—´çš„éçº¿æ€§å…³ç³»ã€‚
  3. ç‰¹å¾ç»„åˆï¼šé€šè¿‡å¯¹ä¸åŒç‰¹å¾è¿›è¡Œç»„åˆï¼ˆæ¯”å¦‚ç›¸ä¹˜ã€ç›¸åŠ ç­‰ï¼‰ï¼Œå¯ä»¥åˆ›é€ æ–°çš„ç‰¹å¾ï¼Œä»è€Œæ›´å¥½åœ°æ•æ‰ç‰¹å¾ä¹‹é—´çš„äº¤äº’ä½œç”¨ã€‚
  4. æ ‡å‡†åŒ–ï¼šå°†åŸå§‹æ•°æ®è½¬æ¢ä¸ºzåˆ†æ•°ï¼Œæœ‰åŠ©äºç¡®ä¿ä¸åŒå˜é‡å…·æœ‰ç›¸ä¼¼çš„å°ºåº¦å’Œåˆ†å¸ƒï¼Œä»¥ä¾¿åœ¨åç»­åˆ†æä¸­è¿›è¡Œæ¯”è¾ƒå’Œç»„åˆã€‚
  5. è¡ç”Ÿç‰¹å¾ï¼šé€šè¿‡ç»“åˆä¸åŒç‰¹å¾ï¼Œå¯ä»¥è¡ç”Ÿå‡ºå…·æœ‰å®é™…æ„ä¹‰çš„æ–°ç‰¹å¾ï¼Œè¿™äº›ç‰¹å¾å¯èƒ½æ›´å¥½åœ°åæ˜ äº†æ•°æ®çš„å†…åœ¨è§„å¾‹ã€‚

  ![1709282240029](image/Multi-ClassPredictionofCirrhosisOutcomes/1709282240029.png)
* åˆ›å»ºé™„åŠ ç‰¹å¾çš„Piplineï¼šhttps://www.kaggle.com/code/markuslill/s3e26-xgbclassifer?scriptVersionId=155390950&cellId=31
* å¼‚å¸¸å€¼å¤„ç†ï¼šæ•°å­—ç‰¹å¾çœ‹èµ·æ¥â€œæœ‰ç‚¹â€æ­£æ€åˆ†å¸ƒã€‚å› æ­¤ï¼Œç‰¹å¾å€¼ä¸å¹³å‡å€¼ç›¸å·®è¶…è¿‡ 6 ä¸ªæ ‡å‡†å·®çš„è§‚æµ‹å€¼è¢«è§†ä¸ºå¼‚å¸¸å€¼ï¼Œæˆ‘ä»¬å¸Œæœ›å°†å…¶åˆ é™¤ã€‚
* æ¨¡å‹é€‰æ‹©ï¼š

  ![1709283096701](image/Multi-ClassPredictionofCirrhosisOutcomes/1709283096701.png)
* ![1709283154412](image/Multi-ClassPredictionofCirrhosisOutcomes/1709283154412.png)

  ![1709283245060](image/Multi-ClassPredictionofCirrhosisOutcomes/1709283245060.png)
* ç®±çº¿å›¾è§‚å¯Ÿè®­ç»ƒé›†å’ŒéªŒè¯é›†ä¸Šæ¨¡å‹çš„æ€§èƒ½ï¼šhttps://www.kaggle.com/code/markuslill/s3e26-xgbclassifer?scriptVersionId=155390950&cellId=52
* CV åæ¨¡å‹ï¼ˆé‡æ–°ï¼‰æ‹Ÿåˆï¼šhttps://www.kaggle.com/competitions/playground-series-s3e26/discussion/459897#2552033
* æ¨¡å‹é›†æˆæ–¹æ³•ï¼š[stacking](https://machinelearningmastery.com/stacking-ensemble-machine-learning-with-python/)

  ![1709284140127](image/Multi-ClassPredictionofCirrhosisOutcomes/1709284140127.png)![1709284178470](image/Multi-ClassPredictionofCirrhosisOutcomes/1709284178470.png)
* çœ‹èµ·æ¥ï¼ˆå½“æˆ‘ä»¬æƒ³åˆ©ç”¨/é›†æˆä¸¤ç§æ–¹æ³•æ—¶ï¼‰ï¼Œæˆ‘ä»¬åº”è¯¥ä¸ºæ¯ä¸ªæ¨¡å‹ä½¿ç”¨ä¸åŒçš„ç‰¹å¾ï¼šhttps://www.kaggle.com/code/markuslill/s3e26-xgbclassifer?scriptVersionId=155390950&cellId=61

### 1.2 [PS3E26 ğŸ”¥ | Liver Cirrhosis | EDA | Model âœ](https://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model)

1. æ•°æ®é¢„å¤„ç†ï¼š

   * åˆ é™¤Â DrugÂ åˆ—ä¸­å­˜åœ¨ç¼ºå¤±å€¼ (NA) çš„æ‰€æœ‰è¡Œ
   * ç”¨å¹³å‡ç»“æœä¼°ç®—ç¼ºå¤±å€¼
   * å¯¹æ‰€æœ‰ç±»åˆ«å±æ€§è¿›è¡Œ One-hot ç¼–ç 
2. åˆ†æåˆæˆæ•°æ®å’ŒåŸå§‹æ•°æ®åˆ†å¸ƒå‘ç°ï¼š

   * Tryglicerides æœ‰ä¸€äº›å¼‚å¸¸å€¼ï¼Œå› ä¸º q3 ä¸º 139ï¼Œä½† ax é«˜è¾¾ 598ï¼šæˆ‘ä»¬éœ€è¦å¯¹å…¶ä½¿ç”¨ **RobustScaler**ï¼Œå°†å…¶é™åˆ¶åœ¨ IQR å†…
   * åŒæ ·ï¼ŒAlk_Phos ä¹Ÿæœ‰è®¸å¤šå¼‚å¸¸å€¼ï¼Œéœ€è¦ä½¿ç”¨ RobustScaler é‡æ–°ç¼©æ”¾
   * èƒ†å›ºé†‡ã€èƒ†çº¢ç´ å’Œå‡è¡€é…¶åŸä¹Ÿç›¸åŒ
   * ğŸ¤©ç»˜åˆ¶æ¯ä¸€ç‰¹å¾å…³äºç›®æ ‡åˆ—æ¯ä¸€åˆ†ç±»çš„å°æç´å›¾ï¼šhttps://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model?scriptVersionId=156056966&cellId=66
   * ğŸ¤©åŸå§‹æ•°æ®å’Œåˆæˆæ•°æ®åœ¨æ¯ä¸€åˆ—ä¸Šçš„å°æç´åˆ†å¸ƒå›¾ï¼šhttps://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model?scriptVersionId=156056966&cellId=63
   * D ç±»æ‚£è€…ä¼¼ä¹ä¸ C ç±»å’Œ CL ç±»æ‚£è€…æœ‰å¾ˆå¤§ä¸åŒã€‚åŒºåˆ† D ä¸ C å’Œ CL ä¼šæ›´å®¹æ˜“ã€‚æŒ‘æˆ˜éƒ¨åˆ†æ˜¯å‡†ç¡®ç¡®å®š CL çº§æ‚£è€…å¹¶å°†å…¶ä¸ C çº§æ‚£è€…åŒºåˆ†å¼€æ¥
3. ğŸ¤©ä½¿ç”¨TimeLinksè¿›è¡Œä¸‹é‡‡æ ·ï¼šhttps://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model?scriptVersionId=156056966&cellId=89
4. ğŸ¤©åˆ†å±‚KæŠ˜CVæœ€ä½³å®è·µï¼šhttps://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model?scriptVersionId=156056966&cellId=95
5. ğŸ¤©ä½¿ç”¨shapåº“è¿›è¡Œç‰¹å¾é‡è¦æ€§è§£é‡Šï¼šhttps://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model?scriptVersionId=156056966&cellId=96
6. ğŸ¤©[XGBã€CATBOOST å’Œ LGBM çš„ç»„åˆ]()æŠ•ç¥¨æ¨¡å‹é›†æˆï¼šhttps://www.kaggle.com/code/ashishkumarak/ps3e26-liver-cirrhosis-eda-model?scriptVersionId=156056966&cellId=105

   ![1709563100134](image/Multi-ClassPredictionofCirrhosisOutcomes/1709563100134.png)

### 1.3[Medical Analysis-Added 21 Features | XGB](https://www.kaggle.com/code/omega11/medical-analysis-added-21-features-xgb)


### 1.4[PS3E26 | Cirrhosis Survial Prediction | Multiclass](https://www.kaggle.com/code/arunklenin/ps3e26-cirrhosis-survial-prediction-multiclass)


### 1.5[PS-S3-Ep26 | EDA ğŸ“Š | Modeling + Submission ğŸš€](https://www.kaggle.com/code/oscarm524/ps-s3-ep26-eda-modeling-submission)


## **2.å¾—åˆ†æœ€é«˜çš„ç¬”è®°æœ¬**

### 2.1[Medical Analysis-Added 21 Features | XGB](https://www.kaggle.com/code/omega11/medical-analysis-added-21-features-xgb)

1. è§£å†³ç›®æ ‡ç±»åˆ«ä¸å¹³è¡¡ï¼ˆæ•ˆæœä¸å¥½ï¼‰ï¼š[æ¢ç´¢SMOTEç®—æ³• - çŸ¥ä¹ (zhihu.com)](https://zhuanlan.zhihu.com/p/275744968)
2. æŸ¥çœ‹æ•°æ®ç‰¹å¾çš„æ­£å¸¸åˆ†å¸ƒèŒƒå›´ï¼š`train_data.describe()`
3. ä¸åŒç±»å‹çš„ç‰¹å¾é‡‡ç”¨ä¸åŒçš„ç¼–ç æ–¹å¼ï¼Œç”šè‡³æ ¹æ®ç‰¹å¾çš„å…·ä½“å«ä¹‰åˆ›å»ºç‹¬ç‰¹çš„ç¼–ç æ–¹å¼ï¼šhttps://www.kaggle.com/code/omega11/medical-analysis-added-21-features-xgb?scriptVersionId=157737446&cellId=22

   * **`OrdinalEncoder`**ï¼š`Drug`ã€`Sex`ã€`Ascites`ã€`Hepatomegaly`ã€`Spiders`å’Œ `Stage`è¿›è¡Œç¼–ç 
   * **`OneHotEncoder`**ï¼š`Edema`
   * `LabelEncoder`ï¼š`LABEL`
4. è½»æ¾åº”ç”¨ä¸Šè¿°é€ç‰¹å¾è¿›è¡Œä»£ç å—ï¼šhttps://www.kaggle.com/code/omega11/medical-analysis-added-21-features-xgb?scriptVersionId=157737446&cellId=24
5. åˆ›å»ºé¢å¤–ç‰¹å¾ï¼š

   * **`DiagnosisDateTransformer`** ï¼šè®¡ç®—è¯Šæ–­æ—¥æœŸã€‚é€šè¿‡ä»æ‚£è€…çš„å¹´é¾„ä¸­å‡å»å·²çŸ¥æ‚£ç—…å¤©æ•°ï¼Œä¼°ç®—å‡ºæ‚£è€…è¢«è¯Šæ–­å‡ºç–¾ç—…çš„å¤§è‡´æ—¥æœŸã€‚
   * **`AgeYearsTransformer`** ï¼šå°†å¹´é¾„è½¬æ¢ä¸ºå¹´ï¼Œå¹¶å¯¹æ‚£ç—…å¤©æ•°è¿›è¡Œç¼©æ”¾ã€‚è¿™æœ‰åŠ©äºæ¨¡å‹æ›´å¥½åœ°ç†è§£æ—¶é—´ç›¸å…³çš„ç‰¹å¾ã€‚
   * **`AgeGroupsTransformer`** ï¼šå°†å¹´é¾„åˆ†ç»„ã€‚åŸºäºå¹´é¾„å°†æ‚£è€…åˆ†ä¸ºä¸åŒçš„ç»„åˆ«ï¼Œä»¥æ¢ç´¢å¹´é¾„å¦‚ä½•å½±å“ç–¾ç—…çš„å‘å±•ã€‚
   * **`BilirubinAlbuminTransformer`** ï¼šåˆ›å»ºèƒ†çº¢ç´ å’Œç™½è›‹ç™½çš„äº¤äº’é¡¹ã€‚è¿™å¯èƒ½æ­ç¤ºè¿™ä¸¤ä¸ªç”ŸåŒ–æŒ‡æ ‡ç›¸äº’ä½œç”¨å¯¹ç–¾ç—…è¿›ç¨‹çš„å½±å“ã€‚
   * **`DrugEffectivenessTransformer`** ï¼šè®¡ç®—è¯ç‰©æ•ˆæœçš„ç‰¹å¾ã€‚è¿™ä¸ªè½¬æ¢å™¨ä¼¼ä¹è¯•å›¾é€šè¿‡è¯ç‰©ç±»å‹å’Œèƒ†çº¢ç´ æ°´å¹³çš„ä¹˜ç§¯æ¥è¯„ä¼°è¯ç‰©çš„æ•ˆæœï¼Œä½†ç”±äº `Drug`æ˜¯åˆ†ç±»å˜é‡ï¼Œç›´æ¥ä¹˜æ³•å¯èƒ½ä¸é€‚ç”¨ï¼Œéœ€è¦è¿›ä¸€æ­¥çš„è°ƒæ•´æˆ–è§£é‡Šã€‚
   * **`SymptomScoreTransformer`** ï¼šè®¡ç®—ç—‡çŠ¶åˆ†æ•°ã€‚é€šè¿‡å¯¹ä¸€ç³»åˆ—ç—‡çŠ¶æŒ‡æ ‡è¿›è¡Œæ±‚å’Œï¼Œä¸ºæ¯ä¸ªæ‚£è€…ç”Ÿæˆä¸€ä¸ªç—‡çŠ¶åˆ†æ•°ã€‚
   * **`SymptomCatTransformer`** ï¼šå°†ç—‡çŠ¶ä¿¡æ¯è¿›è¡Œç‹¬çƒ­ç¼–ç ã€‚é¦–å…ˆå°†å¤šä¸ªç—‡çŠ¶æŒ‡æ ‡åˆå¹¶ä¸ºä¸€ä¸ªå­—ç¬¦ä¸²ï¼Œç„¶åä½¿ç”¨ç‹¬çƒ­ç¼–ç è½¬æ¢ï¼Œè¿™å¯ä»¥å¸®åŠ©æ¨¡å‹æ›´å¥½åœ°ç†è§£ç—‡çŠ¶ç»„åˆçš„å¤æ‚æ€§ã€‚
   * **`LiverFunctionTransformer`** ï¼šè®¡ç®—è‚åŠŸèƒ½æŒ‡æ•°ã€‚é€šè¿‡å¯¹å‡ ä¸ªä¸è‚åŠŸèƒ½ç›¸å…³çš„æŒ‡æ ‡æ±‚å¹³å‡å€¼ï¼Œç”Ÿæˆä¸€ä¸ªç»¼åˆçš„è‚åŠŸèƒ½æŒ‡æ•°ã€‚
   * **`RiskScoreTransformer`** ï¼šè®¡ç®—é£é™©åˆ†æ•°ã€‚ç»“åˆèƒ†çº¢ç´ ã€ç™½è›‹ç™½å’Œç¢±æ€§ç£·é…¸é…¶ï¼ˆAlk_Phosï¼‰æ¥è¯„ä¼°æ‚£è€…çš„å¥åº·é£é™©ã€‚
   * **`TimeFeaturesTransformer`** ï¼šæå–æ—¶é—´ç‰¹å¾ã€‚å°†æ‚£ç—…å¤©æ•°è½¬æ¢ä¸ºè¯Šæ–­å¹´ä»½å’Œæœˆä»½ï¼Œå¯èƒ½æœ‰åŠ©äºæ­ç¤ºç–¾ç—…è¿›ç¨‹éšæ—¶é—´çš„å˜åŒ–ã€‚
   * **`ScalingTransformer`** ï¼šå¯¹æ•°å€¼å‹ç‰¹å¾è¿›è¡Œæ ‡å‡†åŒ–å¤„ç†ã€‚è¿™æ˜¯æœºå™¨å­¦ä¹ ä¸­å¸¸è§çš„é¢„å¤„ç†æ­¥éª¤ï¼Œæœ‰åŠ©äºæ¨¡å‹æ›´å¥½åœ°å­¦ä¹ å’Œæ”¶æ•›ã€‚
6. å¼‚å¸¸å€¼æ£€æµ‹ï¼šç‰¹å¾å€¼ä¸å¹³å‡å€¼ç›¸å·®è¶…è¿‡ 6 ä¸ªæ ‡å‡†å·®çš„è§‚æµ‹å€¼è¢«è§†ä¸ºå¼‚å¸¸å€¼ï¼Œæˆ‘ä»¬å¸Œæœ›å°†å…¶åˆ é™¤ã€‚
7. è®¡ç®—åå·®ç‰¹å¾å¹¶åˆ›å»ºâ€œ_is_normalâ€ç‰¹å¾ï¼šæœ€åˆçš„é¥¼å›¾è¯´æ˜äº†æ­£å¸¸èŒƒå›´å†…å’Œä¹‹å¤–çš„æ‚£è€…åˆ†å¸ƒï¼Œ**ä½†æ²¡æœ‰æŒ‡å®šæ˜¯ä½äºè¿˜æ˜¯é«˜äº**ï¼é‡è¦çš„æ˜¯è¦è®¤è¯†åˆ°ï¼Œä»åŒ»å­¦è§’åº¦æ¥çœ‹ï¼Œå¹¶éæ‰€æœ‰ç‰¹å¾åœ¨æ­£å¸¸èŒƒå›´ä¹‹å¤–éƒ½ä¼šå¸¦æ¥é£é™©ã€‚ä¾‹å¦‚ï¼Œç™½è›‹ç™½ä½äºæ­£å¸¸èŒƒå›´æ—¶å­˜åœ¨é£é™©ï¼Œè€Œèƒ†çº¢ç´ é«˜äºæ­£å¸¸èŒƒå›´æ—¶å­˜åœ¨é£é™©ã€‚å› æ­¤ï¼Œå¯¹æ‰€æœ‰ç‰¹å¾é‡‡ç”¨äºŒå…ƒæ–¹æ³•ï¼ˆæ­£å¸¸èŒƒå›´å†…/æ­£å¸¸èŒƒå›´å¤–ï¼‰å¯èƒ½å¹¶ä¸åˆé€‚ã€‚ç›¸åï¼Œæˆ‘ä»¬åº”è¯¥å°†å®ƒä»¬åˆ†ç±»ä¸ºä¸Šé¢ï¼ˆå¯¹äºå¤§å¤šæ•°åŠŸèƒ½ï¼‰ã€ä¸‹é¢ï¼ˆå¯¹äºç™½è›‹ç™½ï¼‰æˆ–ä¸¤è€…ï¼ˆå¯¹äºè¡€å°æ¿ï¼‰ã€‚
8. åå·®åˆ—çš„æœ€ç»ˆå½¢çŠ¶ï¼šè´Ÿåå·®ï¼ˆåŸæœ¬ä½äºæ­£å¸¸èŒƒå›´çš„å€¼ï¼‰/ æ­£åå·®ï¼ˆåŸæœ¬é«˜äºæ­£å¸¸èŒƒå›´çš„å€¼ï¼‰/ é›¶åå·®ï¼ˆåŸæœ¬åœ¨æ­£å¸¸èŒƒå›´å†…çš„å€¼ï¼‰ã€‚
9. ç‰¹æ®Šæ¨¡å¼ï¼šæŸäº›ç‰¹å¾åœ¨ä½äºæ­£å¸¸èŒƒå›´æ—¶ä¼šå¸¦æ¥æ›´å¤§çš„é£é™©ï¼Œè€Œåœ¨é«˜äºæ­£å¸¸èŒƒå›´æ—¶åˆ™ç›¸åã€‚ç™½è›‹ç™½çš„ç‹¬ç‰¹æ¨¡å¼ - æ¯ä¸ªå»ä¸–çš„äººçš„ç™½è›‹ç™½æ°´å¹³éƒ½ä½äºæ­£å¸¸èŒƒå›´ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼Œå¯¹äºå¤§å¤šæ•°å…¶ä»–ç‰¹å¾ï¼Œè¯»æ•°ä¸»è¦é«˜äºæ­£å¸¸èŒƒå›´ã€‚
10. ä»è®ºæ–‡ä¸­å‘æ˜æ–°ç‰¹å¾ï¼šç™½è›‹ç™½-èƒ†çº¢ç´ çš„æ–°åŠŸèƒ½ï¼Œè¯¥è®ºæ–‡å¼ºè°ƒäº†ç”¨ä½œè‚è„ç›¸å…³æ­»äº¡ç‡é¢„æµ‹å› å­çš„å„ç§ç›¸å…³ç‰¹å¾ï¼ŒåŒ…æ‹¬æ¢…å¥¥è¯„åˆ†ã€‚å…³äº ALBIï¼Œç ”ç©¶è®ºæ–‡æŒ‡å‡ºï¼Œæ ¹æ® ALBI å€¼å°†æ‚£è€…åˆ†ä¸ºä¸‰ç»„ï¼Œå¦‚ä¸‹å›¾æ‰€ç¤ºã€‚å› æ­¤ï¼Œæˆ‘å°†åœ¨åˆ†æä¸­åŒ…æ‹¬ALBI_statusã€‚

    ![1709472836022](image/Multi-ClassPredictionofCirrhosisOutcomes/1709472836022.png)
11. PCAï¼šæˆ‘ä»æ€»å…± 72 ä¸ªç‰¹å¾ä¸­é€‰æ‹©äº†å¤§çº¦ 30 ä¸ªè¿›è¡Œè®­ç»ƒã€‚MLmosaic æå‡ºäº†ä¸€ç§æœ‰æ•ˆç­–ç•¥ï¼Œå°†å‰©ä½™ç‰¹å¾ç”¨äºä¸»æˆåˆ†åˆ†æ (PCA)ã€‚ç»è¿‡å¤šæ¬¡è¯•éªŒï¼Œæˆ‘ç¡®å®šäº† PCA æ•´åˆçš„æœ€ä½³ç‰¹å¾ä»¥åŠä¸ºè®­ç»ƒç›®çš„è€Œä¿ç•™çš„ç‰¹å¾ã€‚Mayo é£é™©è¯„åˆ†å’Œ ALBI è¢«æ”¾å…¥ PCAï¼Œè€Œ **ALBI_status è¢«ä¿ç•™ç”¨äºç›´æ¥è®­ç»ƒç›®çš„ï¼›**è§£é‡Šçš„æ–¹å·®æ¯”**ï¼šè¿™è¡¨ç¤ºç¬¬ä¸€ä¸»æˆåˆ†ä¿ç•™äº†åŸå§‹æ•°æ®å¤šå°‘ç™¾åˆ†æ¯”çš„æ–¹å·®ï¼ˆæˆ–ä¿¡æ¯ï¼‰ã€‚è¿™ä¸ªæŒ‡æ ‡æœ‰åŠ©äºè¯„ä¼°é™ç»´çš„æ•ˆæœã€‚**
12. å¹³å‡æŠ•ç¥¨åˆ†ç±»å™¨ `MyAvgVoting`ï¼šhttps://www.kaggle.com/code/omega11/medical-analysis-added-21-features-xgb?scriptVersionId=157737446&cellId=75
13. ç»“åˆå…¶ä»–æ–¹æ¡ˆç»“æœçš„ä»£ç æ®µï¼š

## **3.é«˜åˆ†æ–¹æ³•ä¸è®¨è®º**
